Related Experiment Video
Updated: Jul 29, 2026

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism
Surgery
|December 1, 1992
Summary
Early surgery for primary aldosteronism improves outcomes. Older age, male sex, and adenoma with macronodules predict persistent hypertension after adrenalectomy, impacting patient management.
Area of Science:
- Endocrinology
- Surgical Oncology
- Hypertension Research
Background:
- Primary aldosteronism is a condition leading to excess aldosterone production.
- Unilateral adrenalectomy is a common treatment for primary aldosteronism.
- While effective in resolving hyperaldosteronism, persistent hypertension remains a challenge in 38% of patients post-surgery.
Purpose of the Study:
- To identify key factors predicting persistent hypertension after unilateral adrenalectomy for primary aldosteronism.
- To guide clinical decision-making and patient counseling regarding surgical outcomes.
Main Methods:
- A retrospective analysis of 63 patients who underwent unilateral adrenalectomy.
- Stepwise multivariate logistic regression was employed to evaluate clinicopathologic predictors of persistent hypertension.
Main Results:
- Age (≥50 years), male sex, and specific pathological findings (multiple adenomas or adenoma with macronodules) were significant predictors of persistent hypertension.
- Older patients (≥50) had a 10.6-fold increased odds of persistent hypertension compared to younger patients (<40).
- Male patients (OR 5.9) and those with specific adenoma types (OR 8.1) also showed significantly higher odds of persistent hypertension.
Conclusions:
- Early surgical intervention in younger patients with primary aldosteronism is associated with better long-term outcomes.
- The presence of macronodules alongside an adenoma serves as a crucial indicator for potential persistent hypertension post-adrenalectomy.
Related Concept Videos
Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

